Does TREPROSTINIL Cause Left ventricular hypertrophy? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Left ventricular hypertrophy have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
18
Reports of Left ventricular hypertrophy with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
1
Deaths
12
Hospitalizations
How Dangerous Is Left ventricular hypertrophy From TREPROSTINIL?
Of the 18 reports, 1 (5.6%) resulted in death, 12 (66.7%) required hospitalization, and 1 (5.6%) were considered life-threatening.
Is Left ventricular hypertrophy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Left ventricular hypertrophy?
AMLODIPINE (158)
CLOZAPINE (149)
TACROLIMUS (135)
FUROSEMIDE (128)
PANTOPRAZOLE (117)
BISOPROLOL (114)
SACUBITRIL\VALSARTAN (105)
ASPIRIN (104)
ROSUVASTATIN (94)
CARVEDILOL (87)
Which TREPROSTINIL Alternatives Have Lower Left ventricular hypertrophy Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE